Monashee Investment Management’s Tectonic Therapeutic TECX Stock Holding History
Bought
Maintained
Sold
Other funds holding TECX
CCM
GC
ACM
EMFAT
Monashee Investment Management's TECX Position: Q1 2021 in Review
Monashee Investment Management sold out of Tectonic Therapeutic (TECX) in Q1 2021, closing a stake of 2,457 shares — an estimated $411K sold.
Monashee Investment Management first reported a position in TECX in Q4 2020 and held it in 1 quarter. The position peaked at $411K in Q4 2020. 99 funds tracked by Wall St. Rank hold TECX as of Q1 2021.
- Monashee Investment Management reported no remaining Tectonic Therapeutic position as of Q1 2021 after selling out during the quarter.
- Monashee Investment Management sold 2,457 Tectonic Therapeutic shares in Q1 2021, an estimated $411K.
- Monashee Investment Management first reported a position in Tectonic Therapeutic in Q4 2020 and held it in 1 quarter.
- Monashee Investment Management's Tectonic Therapeutic position peaked at $411K in Q4 2020.
- 99 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q1 2021.
Based on Monashee Investment Management's 13F filing for Q1 2021, filed 14 May 2021.